TP53 and urothelial carcinoma: In another study conducted by Toktas in Turkey, correlated nuclear p53 accumulation with prognosis, they include total 90 patients of urothelial carcinomas, using old version of WHO classification and found that those tumors which expressed p53 had higher rate of recurrence and progression and shorter survival[16].